Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29088582 | 1.00 | KDM4C (0.47) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL8802049 | 1.00 | KDM4C (0.47) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL8798738 | 1.00 | KDM4C (0.47) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL8797924 | 1.00 | KDM4C (0.47) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL5311493 | 0.90 | — | — | |
| SCHEMBL28995086 | 0.85 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL8039193 | 0.85 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL28393903 | 0.85 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL31300438 | 0.85 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2ACA1 | |
| SCHEMBL28399899 | 0.85 | KDM4C (0.50) | KDM4CKDM4APHF8KDM2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8883710-B2 | Compositions and methods incorporating photocatalysts | THE PROCTER & GAMBLE COMPANY (US) | 2014-11-11 | — | — | US | disclosed |
| EP-2727578-A2 | Compositions and methods incorporating photocatalysts | The Procter and Gamble Company (US) | 2014-05-07 | — | — | EP | disclosed |
| US-8349780-B2 | Compositions and methods incorporating photocatalysts | THE PROCTER & GAMBLE COMPANY (US) | 2013-01-08 | — | — | US | disclosed |
| US-20110114108-A1 | Compositions and Methods Incorporating Photocatalysts | THE PROCTER & GAMBLE COMPANY | 2011-05-19 | — | — | US | disclosed |
| US-20100247800-A1 | Compositions and Methods Incorporating Photocatalysts | THE PROCTER & GAMBLE COMPANY | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110114108-A1 | Compositions and Methods Incorporating Photocatalysts | LPO, TYR, MPO | KDM4C 1730/4885KDM4A 2370/4885PHF8 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.